D-0516-2016 Class II Terminated
FDA drug recall D-0516-2016 was initiated by RemedyRepack Inc. on Nov 11, 2015 and is designated Class II. Reason for recall: Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions. The recall status is terminated (terminated Nov 1, 2016). Affected quantity: 106 Vials.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 16, 2015
- Initiation Date
- Nov 11, 2015
- Termination Date
- Nov 1, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 106 Vials
Product description
Novolin 70/30, 100 Units/mL Solu., Qty: 1 Vial, MFG by: Novo Nordisk, A/S, Bagsvaerd, Denmark DK-2880, Repackaged by: RemedyRepack Inc., 625 Kolter Dr., Indiana, PA 15701, NDC 52125-0414-01
Reason for recall
Labeling: Incorrect Instructions; RemedyRepack, Inc. a relabeler, is recalling these products due to incorrect storage instructions.
Distribution pattern
Nationwide
Code information
LOT#:QM114CZF0496, Exp 01/2016; B0025373-050514, B0029738-060914, Exp 02/2016; B0029737-060914, Exp 03/2016.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0516-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026